SHARE

Medical Marijuana Inc (OTCMKTS:MJNA), a leading medical marijuana developer and distributor, is pleased to announce that HempMeds has participated in New York Cannabis World Congress & Business Expo. As per the reports, New York is getting ready to make available medical marijuana for everyone, which prompted the International Cannabis Association to organize this event in the city.

With the successful execution of this mega event, the International Cannabis Association seeks companies and individuals to gather positive points about medical marijuana. The government is planning to allow the cultivation, distribution and usage of medical marijuana in New York City soon.

Insights On Matter:

The event featured a massive crowd and gave Medical Marijuana a chance to showcase a wide range of industrial hemp oil products including RSHO. The Real Scientific Hemp Oil or RSHO has already performed extremely well in the Brazilian market. It is steadily shaping the hemp related laws in the country. Medical Marijuana hopes that New York will also act the way Brazil did, and accept RSHO diligently.

The senior management team of Medical Marijuana is aware of the present state of cannabis law in New York. According to Stuart W. Titus, CEO, Medical Marijuana Inc (OTCMKTS:MJNA), things have improved over the past 6-8 months. However, it will still take more than a year for the medical cannabis law in New York to get regularized. HempMeds presented some of the most innovative cannabis products during the New York Cannabis World Congress & Business Expo to give all the business people an idea of how far things can go. These products are important for those entrepreneurs, who want to target the retail market.

Dr. Titus states that different products of the company are performing well across the world; hence, Medical Marijuana hopes that people in New York will also like them. The company will soon come up with new and fresh products exclusively for New York market, details of which will be shared at a later date.

LEAVE A REPLY